000 | 01055 a2200313 4500 | ||
---|---|---|---|
005 | 20250517081347.0 | ||
264 | 0 | _c20160614 | |
008 | 201606s 0 0 eng d | ||
022 | _a1756-1833 | ||
024 | 7 |
_a10.1136/bmj.i734 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, A David | |
245 | 0 | 0 |
_aDecision on folic acid fortification in Europe must consider both risks and benefits. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cFeb 2016 |
||
300 |
_ai734 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aDietary Supplements _xstatistics & numerical data |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFolic Acid _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNeural Tube Defects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aPregnancy Complications |
700 | 1 | _aRefsum, Helga | |
700 | 1 | _aSelhub, Jacob | |
700 | 1 | _aRosenberg, Irwin H | |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 352 _gp. i734 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.i734 _zAvailable from publisher's website |
999 |
_c25739091 _d25739091 |